Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Divergent Effects of Oxytocin Treatment of Obese Diabetic Mice on Adiposity and Diabetes.

Altirriba J, Poher AL, Caillon A, Arsenijevic D, Veyrat-Durebex C, Lyautey J, Dulloo A, Rohner-Jeanrenaud F.

Endocrinology. 2014 Aug 26:en20141466. [Epub ahead of print]

PMID:
25157455
[PubMed - as supplied by publisher]
2.

Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.

Lee EY, Kim YW, Oh H, Choi CS, Ahn JH, Lee BW, Kang ES, Cha BS, Lee HC.

Metabolism. 2014 Jun;63(6):793-9. doi: 10.1016/j.metabol.2014.02.011. Epub 2014 Feb 25.

PMID:
24684824
[PubMed - indexed for MEDLINE]
3.

The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.

Dubuc PU, Cahn PJ, Willis P.

Int J Obes. 1984;8(3):271-8.

PMID:
6378818
[PubMed - indexed for MEDLINE]
4.

Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats.

Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F.

PLoS One. 2011;6(9):e25565. doi: 10.1371/journal.pone.0025565. Epub 2011 Sep 27.

PMID:
21980491
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical aspects of leptin.

Sinha MK, Caro JF.

Vitam Horm. 1998;54:1-30. Review.

PMID:
9529971
[PubMed - indexed for MEDLINE]
6.

Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice.

Lalonde J, Samson P, Poulin S, Deshaies Y, Richard D.

Physiol Behav. 2004 Jan;80(4):415-20.

PMID:
14741225
[PubMed - indexed for MEDLINE]
7.

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.

Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M.

Gut. 2003 Jul;52(7):947-52.

PMID:
12801949
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Increased sensitivity of the genetically obese mouse to corticosterone.

Tokuyama K, Himms-Hagen J.

Am J Physiol. 1987 Feb;252(2 Pt 1):E202-8.

PMID:
3548420
[PubMed - indexed for MEDLINE]
9.

Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.

Scislowski PW, Tozzo E, Zhang Y, Phaneuf S, Prevelige R, Cincotta AH.

Int J Obes Relat Metab Disord. 1999 Apr;23(4):425-31.

PMID:
10340822
[PubMed - indexed for MEDLINE]
10.

Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.

Prasad Sakamuri SS, Sukapaka M, Prathipati VK, Nemani H, Putcha UK, Pothana S, Koppala SR, Ponday LR, Acharya V, Veetill GN, Ayyalasomayajula V.

PLoS One. 2012;7(12):e50216. doi: 10.1371/journal.pone.0050216. Epub 2012 Dec 17.

PMID:
23284633
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.

Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, Yoon JW, Jun HS.

Diabetes. 2007 Jun;56(6):1671-9. Epub 2007 Mar 16.

PMID:
17369525
[PubMed - indexed for MEDLINE]
Free Article
12.

Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.

Irwin N, Montgomery IA, Moffett RC, Flatt PR.

Biochem Pharmacol. 2013 Jan 1;85(1):81-91. doi: 10.1016/j.bcp.2012.10.008. Epub 2012 Oct 17.

PMID:
23085436
[PubMed - indexed for MEDLINE]
13.

Effects of leptin adipose tissue lipoprotein lipase in the obese ob/ob mouse.

Picard F, Richard D, Huang Q, Deshaies Y.

Int J Obes Relat Metab Disord. 1998 Nov;22(11):1088-95.

PMID:
9822947
[PubMed - indexed for MEDLINE]
14.
15.

Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.

Carmona MC, Louche K, Nibbelink M, Prunet B, Bross A, Desbazeille M, Dacquet C, Renard P, Casteilla L, PĂ©nicaud L.

Int J Obes (Lond). 2005 Jul;29(7):864-71.

PMID:
15917863
[PubMed - indexed for MEDLINE]
16.

PYY transgenic mice are protected against diet-induced and genetic obesity.

Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2008 Feb;42(1):19-30. doi: 10.1016/j.npep.2007.11.003. Epub 2007 Dec 27.

PMID:
18164057
[PubMed - indexed for MEDLINE]
17.

Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.

He M, Su H, Gao W, Johansson SM, Liu Q, Wu X, Liao J, Young AA, Bartfai T, Wang MW.

PLoS One. 2010 Dec 3;5(12):e14205. doi: 10.1371/journal.pone.0014205.

PMID:
21151924
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice.

Hwang IK, Go VL, Harris DM, Yip I, Kang KW, Song MK.

Diabetes Obes Metab. 2003 Sep;5(5):317-24.

PMID:
12940869
[PubMed - indexed for MEDLINE]
19.

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice.

Wang SJ, Birtles S, de Schoolmeester J, Swales J, Moody G, Hislop D, O'Dowd J, Smith DM, Turnbull AV, Arch JR.

Diabetologia. 2006 Jun;49(6):1333-7. Epub 2006 Apr 13.

PMID:
16612591
[PubMed - indexed for MEDLINE]
20.

A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.

Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E.

Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1197-204. doi: 10.1152/ajpendo.00357.2009. Epub 2009 Sep 8.

PMID:
19738035
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk